Bo Hjorth Bentzen

Bo Hjorth Bentzen

Associate Professor


  1. Published

    A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation

    Yfanti, C., Vestbjerg, B., van't Westende, J., Edvardsson, N., Monfort, L. M., Olesen, Morten Steen Salling, Bentzen, Bo Hjorth, Grunnet, Morten, Eveleens Maarse, B. C., Diness, Jonas Goldin, Kemme, M. J. B., Sørensen, U., Moerland, M., van Esdonk, M. J., Klaassen, E. S., Gal, P. & Holst, A. G., 2024, In: British Journal of Clinical Pharmacology. 90, 4, p. 1027-1035

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Gating kinetics and pharmacological properties of small-conductance Ca2+-activated potassium channels

    van Herck, I. G. M., Seutin, V., Bentzen, Bo Hjorth, Marrion, N. V. & Edwards, A. G., 4 Apr 2023, In: Biophysical Journal. 122, 7, p. 1143-1157 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...4 5 6 7 8 Next

ID: 13529